Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05862818 · ClinicalTrials.gov registry record · NA
Can Food Timing Reduce Your Diabetes Risk?
A NA study of Dietary Habits, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05862818: Recruiting NA study of Dietary Habits, sponsored by Brigham and Women's Hospital.
NCT05862818 is a NA study of Dietary Habits that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 48 participants, below the 1,121-participant average among 20 other Dietary Habits trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05862818, a NA study of Dietary Habits, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test whether food timing impacts metabolic health in healthy participants. Participants will: * complete 2 inpatient stays * be provided with test meals * have frequent blood draws
Primary Outcome
Glucose incremental area under the curve (AUC) from mixed meal tests
Conditions Studied
Interventions
- BEHAVIORAL Day shift protocol - Diet order A-B
- BEHAVIORAL Day shift protocol - Diet order B-A
- BEHAVIORAL Night shift protocol - Diet order A-B
- BEHAVIORAL Night shift protocol - Diet order B-A
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT05862818 shows while recruiting
NCT05862818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,121-participant average among 20 other Dietary Habits trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Dietary Habits appearing as the primary indexed condition, and to 4 interventions - of which Day shift protocol - Diet order A-B is the first listed.
NCT05862818 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05862818 about?
NCT05862818 is a clinical study titled "Can Food Timing Reduce Your Diabetes Risk?". The goal of this clinical trial is to test whether food timing impacts metabolic health in healthy participants. Participants will: * complete 2 inpatient stays * be provided with test meals * have frequent blood draws
What is the current status of trial NCT05862818?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2024-12-10. Estimated completion is 2028-06-30.
What conditions does trial NCT05862818 study?
This clinical trial studies the following conditions: Dietary Habits.
What interventions are being tested in trial NCT05862818?
The interventions under investigation include: Day shift protocol - Diet order A-B (BEHAVIORAL), Day shift protocol - Diet order B-A (BEHAVIORAL), Night shift protocol - Diet order A-B (BEHAVIORAL), Night shift protocol - Diet order B-A (BEHAVIORAL).
Who is sponsoring clinical trial NCT05862818?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05862818 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dietary Habits
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05862818's enrollment target sits among peer trials
48 13th of 20 higher than 8 of 20 other Dietary Habits trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dietary Habits trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
RECRUITING · NA
-
Integrating Food Rx With Best Feeding Practices With EFNEP
RECRUITING · NA
-
Nutrition for Precision Health, Powered by the All of Us
RECRUITING · NA
-
Dietary Intervention to Mitigate Adverse Consequences of Night Work
RECRUITING · NA
-
Encouraging a Plant Based Diet in an Underserved Urban Population
RECRUITING · NA
-
Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI